Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 1;60(2):907-910.
doi: 10.1093/rheumatology/keaa610.

COVID-19 and myositis - unique challenges for patients

Latika Gupta  1 , James B Lilleker  2   3 , Vikas Agarwal  1 , Hector Chinoy  3   4   5 , Rohit Aggarwal  6
Affiliations

COVID-19 and myositis - unique challenges for patients

Latika Gupta et al. Rheumatology (Oxford). .

Abstract

Objective: The COVID-19 pandemic and the subsequent effects on healthcare systems is having a significant effect on the management of long-term autoimmune conditions. The aim of this study was to assess the problems faced by patients with idiopathic inflammatory myopathies (IIM).

Methods: An anonymized eSurvey was carried out with a focus on effects on disease control, continuity of medical care, drug procurance and prevalent fears in the patient population.

Results: Of the 608 participants (81.1% female, median (s.d.) age 57 (13.9) years), dermatomyositis was the most frequent subtype (247, 40.6%). Patients reported health-related problems attributable to the COVID-19 pandemic (n = 195, 32.1%); specifically 102 (52.3%) required increase in medicines, and 35 (18%) required hospitalization for disease-related complications. Over half (52.7%) of the surveyed patients were receiving glucocorticoids and/or had underlying cardiovascular risk factors (53.8%), placing them at higher risk for severe COVID-19. Almost one in four patients faced hurdles in procuring medicines. Physiotherapy, critical in the management of IIM, was disrupted in 214 (35.2%). One quarter (159, 26.1%) experienced difficulty in contacting their specialist, and 30 (4.9%) were unable to do so. Most (69.6%) were supportive of the increased use of remote consultations to maintain continuity of medical care during the pandemic.

Conclusion: This large descriptive study suggests that the COVID-19 pandemic has incurred a detrimental effect on continuity of medical care for many patients with IIM. There is concern that delays and omissions in clinical care may potentially translate to poorer outcomes in the future.

Keywords: COVID; coronavirus; dermatomyositis; myositis; pandemic; telemedicine.

PubMed Disclaimer

Figures

<sc>Fig</sc>. 1
Fig. 1
Problems and prevalent fears among patients with myositis
See this image and copyright information in PMC

References

    1. Gupta L, Misra D, Agarwal V, Balan S, Agarwal V. Management of rheumatic diseases in the times of COVID-19 pandemic- perspectives of rheumatology practitioners from India. Rheumatology 2020. - PubMed
    1. https://www.icmr.nic.in/sites/default/files/guidelines/ICMR_Ethical_Guid... (Accessed 21 July 2020).
    1. Eysenbach G. Improving the quality of web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res 2004;6:e34. - PMC - PubMed
    1. Robinson PC, Yazdany J. The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic. Nat Rev Rheumatol 2020;16:293–4. - PMC - PubMed
    1. Gianfrancesco MA, Hyrich KL, Gossec L. et al. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. Lancet Rheumatol 2020;2:e250–e253. - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts